HIV and the key players
Key Correspondents bring the global to the local by reporting how decisions made by governments, international donors, multilateral and bilateral agencies and the private sector affect people's attempts to stay healthy.
KCs also examine the way international agreements such as the Millennium Development Goals and Trade Related Intellectual Property Rights impact on communities most affected by HIV.
Showing 1 - 8 of 63 articles
Health company GlaxoSmithKline has introduced an SMS service dubbed Hakikisha dawa to enhance patient safety by allowing people to check whether GSK branded drugs are real.
more →
December 7, 2012
Author Anthony Aisi
GlaxoSmithKline, one of the world’s leading research-based pharmaceutical and healthcare companies, has ranked highest in the Access to Medicines (ATM) Index for the third time.
more →
November 30, 2012
Author Anthony Aisi
Concerns over a decrease in HIV/AIDS financing and donor prioritisation were expressed during a recent meeting of Irish civil society and the Global Fund for HIV/AIDS, TB and Malaria.
more →
September 24, 2013
Author Brynne Gilmore
A study into the role and contribution of civil society in the contributions to HIV and AIDS in Cambodia shows that civil society cannot work without an enabling environment which includes government stakeholders at national and sub-national levels.
more →
July 13, 2012
Author Channy Chheng
Professor Nkandu Luo has urged African governments to support the development of new drugs against HIV, tuberculosis and malaria by actively contributing towards the European and Developing Countries Clinical Trials Partnership programme.
more →
PEPFAR, one of the biggest donors for HIV programmes in Kenya, has been making steep funding cuts, according to civil society sources.
more →
A Zambian deputy minister of health has admitted rationing HIV treatment but blames UNICEF for the delay in making the lifesaving drugs available.
more →
The Global Fund targets $15 billion to effectively fight AIDS, TB and malaria
more →